Table 2 Summary of Immunohistochemical Abnormalities in PanIN Lesions

From: Multicomponent Analysis of the Pancreatic Adenocarcinoma Progression Model Using a Pancreatic Intraepithelial Neoplasia Tissue Microarray

Protein

Normal Duct Epithelium

PanIN 1A

PanIn 1B

PanIn 2

PanIN 3

P-value*

p16

Present

5/16 (31%)

8/18 (44%)

7/14 (50%)

6/7 (85%)

NS

MUC5

Absent

12/16 (75%)

13/18 (72%)

13/14 (93%)

7/7 (100%)

NS

PSCA

Absent

7/16 (43%)

5/18 (28%)

6/14 (43%)

4/7 (57%)

NS

Fascin

Absent

4/16 (25%)

5/18 (28%)

8/14 (57%)

4/7 (57%)

0.0471

14-3-3σ

Absent

2/16 (13%)

2/18 (11%)

3/14 (21%)

6/7 (85%)

0.0220

MUC1

Present

1/16 (6%)

1/18 (5%)

6/14 (43%)

6/7 (85%)

<0.0001

Mesothelin

Absent

1/16 (6%)

0

2/14 (14%)

1/7 (14%)

NS

Cyclin D1

Absent

0

0

4/14 (29%)

4/7 (57%)

0.0003

Ki-67

Absent

0

0

1/14 (7%)

5/7 (71%)

0.0037

Topo II

Absent

0

0

1/14 (7%)

5/7 (71%)

0.0037

p53

Absent

0

0

0

4/7 (57%)

0.0351

Dpc4/Smad4

Present

0

0

0

2/7 (28%)

NS

MUC2

Absent

0

0

0

0

NS

Beta-catenin (nuclear)

Absent

0

0

0

0

NS

  1. *P values represent the comparison of immunohistochemical abnormalities between “low grade” (PanIN 1A and 1B) versus “high grade” (PanIN 2 and 3) using two-tailed Fisher exact test.